ID

39093

Beschrijving

Safety and Efficacy of BKM120 in Relapsed and Refractory NHL; ODM derived from: https://clinicaltrials.gov/show/NCT01693614

Link

https://clinicaltrials.gov/show/NCT01693614

Trefwoorden

Versies (1)
  1. 01-12-19 01-12-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

1 december 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma NCT01693614

Engels

Eligibility Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma NCT01693614

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patient has a histologically confirmed diagnosis of mantle cell lymphoma, follicular lymphoma, or diffuse large b cell lymphoma.
Beschrijving

Mantle cell lymphoma | Lymphoma, Follicular | Diffuse Large B-Cell Lymphoma

Datatype

boolean

Alias
UMLS CUI [1]
C0334634
UMLS CUI [2]
C0024301
UMLS CUI [3]
C0079744
2. patient has relapsed or refractory disease and received at least one prior therapy.
Beschrijving

Recurrent disease | Refractory Disease | Prior Therapy Quantity

Datatype

boolean

Alias
UMLS CUI [1]
C0277556
UMLS CUI [2]
C1514815
UMLS CUI [3,1]
C1514463
UMLS CUI [3,2]
C1265611
3. patient with diffuse large b cell lymphoma has received or is ineligible for autologous or allogeneic stem cell transplant.
Beschrijving

Diffuse Large B-Cell Lymphoma | Autologous hematopoietic stem cell transplant | Allogeneic hematopoietic stem cell transplant | Patient Ineligible Autologous hematopoietic stem cell transplant | Patient Ineligible Allogeneic hematopoietic stem cell transplant

Datatype

boolean

Alias
UMLS CUI [1]
C0079744
UMLS CUI [2]
C2193200
UMLS CUI [3]
C4255274
UMLS CUI [4,1]
C0030705
UMLS CUI [4,2]
C1512714
UMLS CUI [4,3]
C2193200
UMLS CUI [5,1]
C0030705
UMLS CUI [5,2]
C1512714
UMLS CUI [5,3]
C4255274
4. patient has at least one measurable nodal lesion (≥2 cm) according to cheson criteria (cheson 2007). in case where the patient has no measurable nodal lesions ≥ 2 cm in the long axis at baseline, then the patient must have at least one measurable extra-nodal lesion.
Beschrijving

Lesion nodal Quantity | Measurable lesion nodal Size | Measurable lesion Extranodal Quantity

Datatype

boolean

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C0443268
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0443268
UMLS CUI [2,3]
C0456389
UMLS CUI [3,1]
C1513041
UMLS CUI [3,2]
C1517067
UMLS CUI [3,3]
C1265611
5. patient has an eastern cooperative oncology group (ecog) performance status ≤ 2.
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
6. patient has adequate bone marrow and organ function.
Beschrijving

Bone Marrow function | Organ function

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0678852
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patient has received previous treatment with pi3k inhibitors
Beschrijving

PI3K inhibitor

Datatype

boolean

Alias
UMLS CUI [1]
C1519050
2. patient has evidence of graft versus host disease (gvhd).
Beschrijving

Graft-vs-Host Disease

Datatype

boolean

Alias
UMLS CUI [1]
C0018133
3. patient has active or history of central nervous system (cns) disease.
Beschrijving

CNS disorder

Datatype

boolean

Alias
UMLS CUI [1]
C0007682
4. patient has a concurrent malignancy or has a malignancy within 3 years of study enrollment (with the exception of adequately treated basal or squamous cell carcinoma or non-melanomatous skin cancer).
Beschrijving

Cancer Other | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Skin carcinoma Treated

Datatype

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0007117
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0553723
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0699893
UMLS CUI [4,3]
C1522326
5. patient has a score ≥ 12 on the phq-9 questionnaire.
Beschrijving

Patient Health Questionnaire - 9 Item

Datatype

boolean

Alias
UMLS CUI [1]
C4083201
6. patient has a gad-7 mood scale score ≥ 15.
Beschrijving

GAD-7

Datatype

boolean

Alias
UMLS CUI [1]
C3641330
7. pregnant or nursing women
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
8. patient who does not use highly effective contraception methods to avoid becoming pregnant or conceiving offspring.
Beschrijving

Contraceptive methods Absent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0332197
other protocol-defined inclusion/exclusion criteria may apply.
Beschrijving

Eligibility Criteria Study Protocol

Datatype

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Terug naar het begin van de pagina

Similar models

Eligibility Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma NCT01693614

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Mantle cell lymphoma | Lymphoma, Follicular | Diffuse Large B-Cell Lymphoma
Item
1. patient has a histologically confirmed diagnosis of mantle cell lymphoma, follicular lymphoma, or diffuse large b cell lymphoma.
boolean
C0334634 (UMLS CUI [1])
C0024301 (UMLS CUI [2])
C0079744 (UMLS CUI [3])
Recurrent disease | Refractory Disease | Prior Therapy Quantity
Item
2. patient has relapsed or refractory disease and received at least one prior therapy.
boolean
C0277556 (UMLS CUI [1])
C1514815 (UMLS CUI [2])
C1514463 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Diffuse Large B-Cell Lymphoma | Autologous hematopoietic stem cell transplant | Allogeneic hematopoietic stem cell transplant | Patient Ineligible Autologous hematopoietic stem cell transplant | Patient Ineligible Allogeneic hematopoietic stem cell transplant
Item
3. patient with diffuse large b cell lymphoma has received or is ineligible for autologous or allogeneic stem cell transplant.
boolean
C0079744 (UMLS CUI [1])
C2193200 (UMLS CUI [2])
C4255274 (UMLS CUI [3])
C0030705 (UMLS CUI [4,1])
C1512714 (UMLS CUI [4,2])
C2193200 (UMLS CUI [4,3])
C0030705 (UMLS CUI [5,1])
C1512714 (UMLS CUI [5,2])
C4255274 (UMLS CUI [5,3])
Lesion nodal Quantity | Measurable lesion nodal Size | Measurable lesion Extranodal Quantity
Item
4. patient has at least one measurable nodal lesion (≥2 cm) according to cheson criteria (cheson 2007). in case where the patient has no measurable nodal lesions ≥ 2 cm in the long axis at baseline, then the patient must have at least one measurable extra-nodal lesion.
boolean
C0221198 (UMLS CUI [1,1])
C0443268 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1513041 (UMLS CUI [2,1])
C0443268 (UMLS CUI [2,2])
C0456389 (UMLS CUI [2,3])
C1513041 (UMLS CUI [3,1])
C1517067 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
ECOG performance status
Item
5. patient has an eastern cooperative oncology group (ecog) performance status ≤ 2.
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Organ function
Item
6. patient has adequate bone marrow and organ function.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0678852 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
PI3K inhibitor
Item
1. patient has received previous treatment with pi3k inhibitors
boolean
C1519050 (UMLS CUI [1])
Graft-vs-Host Disease
Item
2. patient has evidence of graft versus host disease (gvhd).
boolean
C0018133 (UMLS CUI [1])
CNS disorder
Item
3. patient has active or history of central nervous system (cns) disease.
boolean
C0007682 (UMLS CUI [1])
Cancer Other | Exception Basal cell carcinoma Treated | Exception Squamous cell carcinoma of skin Treated | Exception Skin carcinoma Treated
Item
4. patient has a concurrent malignancy or has a malignancy within 3 years of study enrollment (with the exception of adequately treated basal or squamous cell carcinoma or non-melanomatous skin cancer).
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0007117 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0553723 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0699893 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
Patient Health Questionnaire - 9 Item
Item
5. patient has a score ≥ 12 on the phq-9 questionnaire.
boolean
C4083201 (UMLS CUI [1])
GAD-7
Item
6. patient has a gad-7 mood scale score ≥ 15.
boolean
C3641330 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
7. pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Contraceptive methods Absent
Item
8. patient who does not use highly effective contraception methods to avoid becoming pregnant or conceiving offspring.
boolean
C0700589 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial